Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque-Type Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT00669916
What this trial is testing

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT02872285
What this trial is testing

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

Who this might be right for
Psoriasis
Lycera Corp. 33
Post-approval studies (Phase 4)Study completedNCT01012713
What this trial is testing

Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
University of California, San Francisco 30
Large-scale testing (Phase 3)Study completedNCT02362789
What this trial is testing

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 132
Testing effectiveness (Phase 2)Study completedNCT00763503
What this trial is testing

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Galderma R&D 26
Large-scale testing (Phase 3)WithdrawnNCT01121081
What this trial is testing

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

Who this might be right for
Psoriasis
Sheba Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT02622386
What this trial is testing

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of Michigan 23
Not applicableLooking for participantsNCT07545902
What this trial is testing

Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis

Who this might be right for
Plaque Type PsorisisNon-pustular Palmoplantar Psoriasis
ICIM International S.r.l. 35
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Testing effectiveness (Phase 2)Looking for participantsNCT07410793
What this trial is testing

Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.

Who this might be right for
Plaque Type Psorisis
Mae Fah Luang University 28
Testing effectiveness (Phase 2)Study completedNCT00885196
What this trial is testing

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

Who this might be right for
Moderate and Severe Plaque Psoriasis
Novartis Pharmaceuticals 336
Large-scale testing (Phase 3)Study completedNCT01636687
What this trial is testing

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 182
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT03337022
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Celgene 34
Testing effectiveness (Phase 2)Study completedNCT00521339
What this trial is testing

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Who this might be right for
Psoriasis-Type PsoriasisPlaque-Type Psoriasis
Amgen 31
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation